In vivo brain glycine and glutamate concentrations in patients with first -
episode psychosis measured by echo time - averaged proton magnetic resonance spectroscopy at 4T Kim SY, Kaufman MJ, Cohen BM, Jensen JE, Coyle JT, Du F, Öngür D. Biological Psychiatry.
This review will consider studies that include the following outcome
measures: the primary outcome is preventing progression to
psychosis (incidences of sub threshold
psychosis and first -
episode psychosis), the secondary outcomes such as symptoms of
psychosis (both positive and negative symptoms), psychosocial functioning, depression, anxiety and quality of life.